Literature DB >> 22075557

Role of hypoxia-inducible-1α in hepatocellular carcinoma cells using a Tet-on inducible system to regulate its expression in vitro.

Zongquan Xu1, Enyu Liu, Cheng Peng, Yunguang Li, Zhaobin He, Chuanzong Zhao, Jun Niu.   

Abstract

Hypoxia-inducible-1α (HIF-1α) expression was intimately correlated with apoptosis and proliferation of cancer cells. However, conclusions of different studies on the effects of HIF-1α expression on cell apoptosis and cell proliferation of hepatoma cells remain controversial. In view of the current status, we reassess its roles and possible mechanism in hepatoma cells. In order to acquire more convincing and reliable results, we used a Tet-on system to stably and effectively regulate HIF-1α expression in the HepG2 cells in vitro. In our study we not only confirmed some common conclusions of previous studies, but also acquired some different and significant results that HIF-1α facilitates cell proliferation and cell cycle through influencing the expression of cyclin A and cyclin D, and suppresses cell apoptosis through inducing the expression of survivin and Bcl-2. These results further enrich our knowledge on the role of HIF-1α expression on cell apoptosis and cell proliferation of hepatoma cells.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22075557     DOI: 10.3892/or.2011.1533

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  9 in total

1.  Bortezomib enhances the radiosensitivity of hypoxic cervical cancer cells by inhibiting HIF-1α expression.

Authors:  Heqing Cui; Qin Qin; Meilin Yang; Hao Zhang; Zheming Liu; Yan Yang; Xiaochen Chen; Hongcheng Zhu; Di Wang; Cuicui Meng; Hongmei Song; Jianxin Ma; Guanhong Huang; Jing Cai; Xinchen Sun; Zhongming Wang
Journal:  Int J Clin Exp Pathol       Date:  2015-08-01

Review 2.  Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.

Authors:  Daniel Lin; Jennifer Wu
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

3.  Arsenic trioxide reduces chemo-resistance to 5-fluorouracil and cisplatin in HBx-HepG2 cells via complex mechanisms.

Authors:  Guifang Yu; Xuezhu Chen; Shudi Chen; Weipeng Ye; Kailian Hou; Min Liang
Journal:  Cancer Cell Int       Date:  2015-12-12       Impact factor: 5.722

4.  Nicotinamide nucleotide transhydrogenase (NNT) deficiency dysregulates mitochondrial retrograde signaling and impedes proliferation.

Authors:  Hung-Yao Ho; Yu-Ting Lin; Gigin Lin; Pei-Ru Wu; Mei-Ling Cheng
Journal:  Redox Biol       Date:  2017-04-29       Impact factor: 11.799

5.  Systems Pharmacology-Based Identification of Mechanisms of Action of Bolbostemma paniculatum for the Treatment of Hepatocellular Carcinoma.

Authors:  Lan-Lan Wang; Chen Liao; Xiao-Qiang Li; Rong Dai; Qing-Wei Ren; Hai-Long Shi; Xiao-Ping Wang; Xue-Song Feng; Xu Chao
Journal:  Med Sci Monit       Date:  2021-01-13

Review 6.  The role of hypoxia inducible factor-1 in hepatocellular carcinoma.

Authors:  Dongjun Luo; Zhongxia Wang; Junyi Wu; Chunping Jiang; Junhua Wu
Journal:  Biomed Res Int       Date:  2014-07-02       Impact factor: 3.411

7.  A controlled double-duration inducible gene expression system for cartilage tissue engineering.

Authors:  Ying Ma; Junxiang Li; Yi Yao; Daixu Wei; Rui Wang; Qiong Wu
Journal:  Sci Rep       Date:  2016-05-25       Impact factor: 4.379

8.  RhoE/ROCK2 regulates chemoresistance through NF-κB/IL-6/ STAT3 signaling in hepatocellular carcinoma.

Authors:  Wei Ma; Karen Man-Fong Sze; Lo Kong Chan; Joyce Man-Fong Lee; Larry Lai Wei; Chun-Ming Wong; Terence Kin-Wah Lee; Carmen Chak-Lui Wong; Irene Oi-Lin Ng
Journal:  Oncotarget       Date:  2016-07-05

9.  HIF-1α RNAi Combined with Asparagus Polysaccharide Exerts an Antiangiogenesis Effect on Hepatocellular Carcinoma In Vitro and In Vivo.

Authors:  Tingting Zhu; Ziwei Cheng; Xiaolin Peng; Dongwei Xing; Minguang Zhang
Journal:  Evid Based Complement Alternat Med       Date:  2021-07-23       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.